Assertio Holdings, Inc., a specialty pharmaceutical company offering differentiated products to patients, announced the pricing of its offering of $60 million aggregate principal amount of 6.50% convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
August 22, 2022
· 5 min read
